Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v6-FR
Language French French
Date Updated 2017-03-29 2017-03-29
Drug Identification Number 00682020 00682020
Brand name ERYTHRO-BASE ERYTHRO-BASE
Common or Proper name ERYTHRO-BASE ERYTHRO-BASE
Company Name AA PHARMA INC AA PHARMA INC
Ingredients ERYTHROMYCIN ERYTHROMYCIN
Strength(s) 250MG 250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1000 BOTTLE 1000 BOTTLE
ATC code J01FA J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2016-10-28 2016-10-28
Actual start date
Estimated end date
Actual end date 2016-10-28 2016-10-28
Shortage status Resolved Resolved
Company comments ERYTHRO-BASE 250MG 100 BOTTLE IS AVAILABLE 1000 BOTTLE DISCONTINUED ERYTHRO-BASE 250MG 100 BOTTLE IS AVAILABLE 1000 BOTTLE DISCONTINUED
Health Canada comments